Home » Topics » Regulatory

Regulatory
RSS

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

FDA approves Somaxon's Silenor for treatment of insomnia

March 19, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

FDA approves Botox for upper limb spasticity in adults

March 11, 2010

FDA approves CSL Behring's Hizentra immunoglobulin therapy

March 8, 2010

FDA grants marketing approval for Shire's VPRIV for type 1 GD

March 1, 2010

FDA approves Novartis' Menveo vaccine for meningococcal disease

Feb. 22, 2010

FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients

Feb. 12, 2010

FDA approves Xiaflex for debilitating hand disease

Feb. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...